cholestyramine resin has been researched along with vasoactive intestinal peptide in 2 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ewe, K | 1 |
| Banks, MR; Kent, AJ | 1 |
2 review(s) available for cholestyramine resin and vasoactive intestinal peptide
| Article | Year |
|---|---|
[Intestinal loss syndromes].
Topics: alpha 1-Antitrypsin; Bacterial Toxins; Cholestyramine Resin; Colonic Diseases; Deoxycholic Acid; Diarrhea; Humans; Immunoglobulin G; Iodine Radioisotopes; Malabsorption Syndromes; Prostaglandins; Protein-Losing Enteropathies; Serum Albumin; Vasoactive Intestinal Peptide; Water-Electrolyte Imbalance | 1979 |
Pharmacological management of diarrhea.
Topics: Anti-Infective Agents; Antidiarrheals; Bismuth; Calcium Channel Blockers; Calmodulin; Chloride Channels; Cholestyramine Resin; Diarrhea; Fluid Therapy; Humans; Narcotics; Neprilysin; Receptors, sigma; Serotonin Antagonists; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2010 |